Immunity
Volume 35, Issue 6, 23 December 2011, Pages 908-918
Journal home page for Immunity

Article
RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome

https://doi.org/10.1016/j.immuni.2011.09.020Get rights and content
Under an Elsevier user license
open archive

Summary

Engagement of tumor necrosis factor receptor 1 signals two diametrically opposed pathways: survival-inflammation and cell death. An additional switch decides, depending on the cellular context, between caspase-dependent apoptosis and RIP kinase (RIPK)-mediated necrosis, also termed necroptosis. We explored the contribution of both cell death pathways in TNF-induced systemic inflammatory response syndrome (SIRS). Deletion of apoptotic executioner caspases (caspase-3 or -7) or inflammatory caspase-1 had no impact on lethal SIRS. However, deletion of RIPK3 conferred complete protection against lethal SIRS and reduced the amounts of circulating damage-associated molecular patterns. Pretreatment with the RIPK1 kinase inhibitor, necrostatin-1, provided a similar effect. These results suggest that RIPK1-RIPK3-mediated cellular damage by necrosis drives mortality during TNF-induced SIRS. RIPK3 deficiency also protected against cecal ligation and puncture, underscoring the clinical relevance of RIPK kinase inhibition in sepsis and identifying components of the necroptotic pathway that are potential therapeutic targets for treatment of SIRS and sepsis.

Highlights

► Necroptosis is a crucial process during lethal SIRS and sepsis ► RIPK3 ablation and RIPK1 inhibition protect mice against TNF-induced lethal SIRS ► Reduced amounts of DAMP release correlate with protection against lethality ► RIPK3 ablation protects against lethal sepsis induced by ceacal ligation and puncture

Cited by (0)

3

These authors contributed equally to this work

4

These authors share senior authorship